MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Authors
Keywords
Glioma, Plasma DNA, MGMT, Methylation, Temozolomide
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 117, Issue 2, Pages 347-357
Publisher
Springer Nature America, Inc
Online
2014-02-12
DOI
10.1007/s11060-014-1395-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival
- (2013) S. Leu et al. NEURO-ONCOLOGY
- O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w
- (2012) Emmanuèle Lechapt-Zalcman et al. CANCER
- Measurement of Circulating Cell-Free DNA in Relation to 18F-Fluorocholine PET/CT Imaging in Chemotherapy-Treated Advanced Prostate Cancer
- (2012) Sandi Kwee et al. CTS-Clinical and Translational Science
- Epigenetic markers of prostate cancer in plasma circulating DNA
- (2012) Rene Cortese et al. HUMAN MOLECULAR GENETICS
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
- (2012) Arne Christians et al. PLoS One
- Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer
- (2012) Christopher P. E. Lange et al. PLoS One
- O6-Methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma
- (2011) Reiko Watanabe et al. Brain Tumor Pathology
- Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer
- (2011) Youwei Zhang et al. CANCER LETTERS
- Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients
- (2011) Carmen Balañá et al. Clinical & Translational Oncology
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis
- (2011) Robert A. Olson et al. JOURNAL OF NEURO-ONCOLOGY
- MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients?
- (2011) Alessandro Della Puppa et al. JOURNAL OF NEURO-ONCOLOGY
- O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications
- (2011) A. A. Brandes et al. NEURO-ONCOLOGY
- Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
- (2011) I. Lavon et al. NEURO-ONCOLOGY
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR
- (2010) K. L. Ostrow et al. CLINICAL CANCER RESEARCH
- Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients
- (2010) Thomas E. Liggett et al. INTERNATIONAL JOURNAL OF CANCER
- Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas
- (2010) Adrian F. Ochsenbein et al. JOURNAL OF NEURO-ONCOLOGY
- Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas
- (2010) B.-L. Liu et al. NEURO-ONCOLOGY
- Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
- (2009) Maniesh van der Vaart et al. CLINICAL BIOCHEMISTRY
- Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer
- (2009) B. B. Lee et al. CLINICAL CANCER RESEARCH
- Classification and management of anaplastic gliomas
- (2009) Wolfgang Wick et al. CURRENT OPINION IN NEUROLOGY
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
- (2008) S. Kesari et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started